These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2023 related items for PubMed ID: 16827732

  • 1. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK, Chen YL, Chang HC, Li CL, Kuo MY.
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [Abstract] [Full Text] [Related]

  • 2. Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis.
    Lin SJ, Chen YL, Kuo MY, Li CL, Lu HK.
    Cytokine; 2005 May 21; 30(4):160-7. PubMed ID: 15863389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients.
    Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J.
    J Periodontol; 2004 Dec 21; 75(12):1586-91. PubMed ID: 15732858
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease.
    Garlet GP, Martins W, Fonseca BA, Ferreira BR, Silva JS.
    J Clin Periodontol; 2004 Aug 21; 31(8):671-9. PubMed ID: 15257746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
    Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Berdeli A, Atilla G, McKay IJ, Hughes FJ, Belibasakis GN.
    J Periodontal Res; 2007 Aug 21; 42(4):287-93. PubMed ID: 17559623
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
    Mogi M, Otogoto J, Ota N, Togari A.
    J Dent Res; 2004 Feb 21; 83(2):166-9. PubMed ID: 14742657
    [Abstract] [Full Text] [Related]

  • 9. Osteoprotegerin and RANKL in alcoholic liver cirrhosis.
    Fábrega E, Orive A, García-Suarez C, García-Unzueta M, Antonio Amado J, Pons-Romero F.
    Liver Int; 2005 Apr 21; 25(2):305-10. PubMed ID: 15780054
    [Abstract] [Full Text] [Related]

  • 10. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.
    Fábrega E, Orive A, García-Unzueta M, Amado JA, Casafont F, Pons-Romero F.
    Clin Transplant; 2006 Apr 21; 20(3):383-8. PubMed ID: 16824158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Apr 21; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 13. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.
    Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H.
    Gut; 2005 Apr 21; 54(4):479-87. PubMed ID: 15753532
    [Abstract] [Full Text] [Related]

  • 14. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS.
    Oral Microbiol Immunol; 2006 Feb 21; 21(1):12-20. PubMed ID: 16390336
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep 21; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 16. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis.
    Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J.
    J Clin Periodontol; 2005 Apr 21; 32(4):383-9. PubMed ID: 15811056
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.
    Buduneli N, Buduneli E, Kütükçüler N.
    J Periodontol; 2009 Aug 21; 80(8):1274-80. PubMed ID: 19656027
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.